Menu Search
Equities

Nakanishi Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NKNSF:PKL

Nakanishi Inc

Actions
  • Price (USD)14.11
  • Today's Change0.00 / 0.00%
  • Shares traded21.46k
  • 1 Year change--
  • Beta0.9195
Data delayed at least 15 minutes, as of Apr 04 2025 14:05 BST.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nakanishi Inc is a Japan-based company mainly engaged in the manufacture and sale of dental medical equipment, dental chairs, and general industrial cutting and grinding equipment. The Company operates through four business segments. The Dental Business segment manufactures and sells treatment handpieces, laboratory micromotors and handpieces, surgical handpieces, and sterilizers. The DCI Business segment manufactures and sells dental chairs and other products. The Surgical Business segment manufactures and sells bone cutting equipment, which is essential for surgical fields such as neurosurgery. The Machinery Business segment manufactures and sells manual grinders and machine-mounted spindles.

  • Revenue in JPY (TTM)79.17bn
  • Net income in JPY6.68bn
  • Incorporated1953
  • Employees2.18k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.